{"id":559621,"date":"2026-06-12T08:00:00","date_gmt":"2026-06-12T06:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/highly-selective-oral-tyk-inhibitors-in-phase-iii\/"},"modified":"2026-06-18T17:17:01","modified_gmt":"2026-06-18T15:17:01","slug":"highly-selective-oral-tyk-inhibitors-in-phase-iii","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/en\/highly-selective-oral-tyk-inhibitors-in-phase-iii\/","title":{"rendered":"Highly selective oral TYK inhibitors in Phase III"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Envudeucitinib and Zasocitinib are oral, allosteric tyrosine kinase 2 (TYK2) inhibitors currently being evaluated in clinical trials for plaque psoriasis. The interim results presented during the Late-Breaking Research sessions at this year\u2019s annual meeting of the <em>American Academy of Dermatology<\/em> (AAD) are drawing attention. Also worth noting is the favorable safety profile, which, combined with the oral dosage form, is a major advantage in terms of convenience.    <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/en\/my-account\/packages\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/en\/log-in\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fen%2Fhighly-selective-oral-tyk-inhibitors-in-phase-iii%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Envudeucitinib and Zasocitinib are oral, allosteric tyrosine kinase 2 (TYK2) inhibitors currently being evaluated in clinical trials for plaque psoriasis. The interim results presented during the Late-Breaking Research sessions at&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/en\/my-account\/packages\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/en\/log-in\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fen%2Fhighly-selective-oral-tyk-inhibitors-in-phase-iii%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":559628,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Psoriasis Research: What's in the Pipeline?  ","footnotes":""},"category":[11548,11331,11513,11340,11442,11480,11503],"tags":[21768,95002,95007,95008,95010,95012,95009,95005,14032,95003,95011],"powerkit_post_featured":[],"class_list":["post-559621","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-en","category-allergology-and-clinical-immunology","category-congress-reports","category-dermatology-and-venereology","category-pharmacology-and-toxicology","category-rheumatology","category-studies","tag-aad-en","tag-american-academy-of-dermatology","tag-convenience","tag-envudeucitinib","tag-interim-results","tag-latitude-3002","tag-latitude-pso-3001","tag-pipeline","tag-psoriasis-en-2","tag-tyk-inhibitors","tag-zasocitinib","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-06-30 09:55:40","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":559631,"slug":"inhibiteurs-oraux-hautement-selectifs-de-la-tyk-en-phase-iii","post_title":"Inhibiteurs oraux hautement s\u00e9lectifs de la TYK en phase III","href":"https:\/\/medizinonline.com\/fr\/inhibiteurs-oraux-hautement-selectifs-de-la-tyk-en-phase-iii\/"},"it_IT":{"locale":"it_IT","id":559641,"slug":"inibitori-orali-altamente-selettivi-della-tyk-in-fase-iii","post_title":"Inibitori orali altamente selettivi della TYK in fase III","href":"https:\/\/medizinonline.com\/it\/inibitori-orali-altamente-selettivi-della-tyk-in-fase-iii\/"},"pt_PT":{"locale":"pt_PT","id":559647,"slug":"inibidores-orais-altamente-seletivos-da-tyk-em-fase-iii","post_title":"Inibidores orais altamente seletivos da TYK em fase III","href":"https:\/\/medizinonline.com\/pt-pt\/inibidores-orais-altamente-seletivos-da-tyk-em-fase-iii\/"},"es_ES":{"locale":"es_ES","id":559650,"slug":"inhibidores-orales-de-tyk-altamente-selectivos-en-fase-iii","post_title":"Inhibidores orales de TYK altamente selectivos en fase III","href":"https:\/\/medizinonline.com\/es\/inhibidores-orales-de-tyk-altamente-selectivos-en-fase-iii\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/559621","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/comments?post=559621"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/559621\/revisions"}],"predecessor-version":[{"id":559629,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/559621\/revisions\/559629"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media\/559628"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media?parent=559621"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/category?post=559621"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/tags?post=559621"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/powerkit_post_featured?post=559621"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}